Demant to divest hearing implant division to Cochlear
Hearing aid manufacturer Demant has announced it will sell its hearing implant business, Oticon Medical, to Cochlear for a total sum of DKK 850m (USD 121.5m). (Updated)
by christian bundgaard, translated by daniel pedersen
On Wednesday, hearing aid manufacturer Demant has announced its intention to divest its hearing implant business, Oticon Medical, which was established in 2007, the company reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant lost ground at Veterans Affairs in March
For subscribers
Demant has long-term expectations in China
For subscribers
.jpg&w=384&q=75)
